![](https://investorshub.advfn.com/uicon/521970.png?cb=1579207683)
Wednesday, October 20, 2021 5:07:12 AM
This deal between Chemdiv, CureVac, and Eli Lilly is massive for all mRNA. And strikes so close to Regen IP that how does one not get excited? Its obvious demand for the exact type of IP that we hold thousands and thousands of hours of data in! And thru our exact same CRO, Chemdiv, that now BRG(big pharma FDA contractor) is suddenly evaluating too? Hello?
NR2F6 is becoming a front running mRNA study. Regen Biopharma owns a massive portion of NR2F6. Tic toc.
Some understand now. All will understand very very soon.
Sometimes its Skil, Sometimes its Luc.
I Appreciate All Member Follows!
Desperate Sellers Become Desperate Buyers. Vice Versa
ALL IMHO.
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM